The Emerging Role of microRNA in Stroke

Current Topics in Medicinal Chemistry

Volumn 13, Issue 13, 2013, Pages 1573-1588

  Koutsis, Georgios ^a   Siasos, Gerasimos ^a   Spengos, Konstantinos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cerebral hemorrhage; Cerebral ischemia; Cerebrovascular disease; MicroRNA; MiRNA; Non coding RNA; Stroke

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 124; MICRORNA 145; MICRORNA 15A; MICRORNA 181; MICRORNA 181A; MICRORNA 21; MICRORNA 210; MICRORNA 29B; MICRORNA 497; UNCLASSIFIED DRUG; VALPROIC ACID;

3' UNTRANSLATED REGION; ARTICLE; ATHEROSCLEROSIS; BIOGENESIS; BRAIN DAMAGE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE CLASSIFICATION; DYSLIPIDEMIA; GENE CONTROL; GENE EXPRESSION PROFILING; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIA; MICROARRAY ANALYSIS; NEUROPROTECTION; NONHUMAN; POLYMERASE CHAIN REACTION; RISK FACTOR; SUBVENTRICULAR ZONE;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; MICRORNAS; PROGNOSIS; STROKE;

EID: 84881360783     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113139990106     Document Type: Article

References (115)

1. Taft, R. J.; Pang, K. C.; Mercer, T. R.; Dinger, M.; Mattick, J. S. Non-coding RNAs: regulators of disease. J Pathol, 2010, 220(2), 126-139.
2. Vemuganti, R. The MicroRNAs and Stroke: No Need to be Coded to be Counted. Transl Stroke Res, 2010, 1(3), 158-160.
3. Ambros, V. microRNAs: tiny regulators with great potential. Cell, 2001, 107(7), 823-826.
4. Reinhart, B. J.; Slack, F. J.; Basson, M.; Pasquinelli, A. E.; Bettinger, J. C.; Rougvie, A. E.; Horvitz, H. R.; Ruvkun, G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000, 403(6772), 901-906.
5. Pasquinelli, A. E.; Reinhart, B. J.; Slack, F.; Martindale, M. Q.; Kuroda, M. I.; Maller, B.; Hayward, D. C.; Ball, E. E.; Degnan, B.; Muller, P.; Spring, J.; Srinivasan, A.; Fishman, M.; Finnerty, J.; Corbo, J.; Levine, M.; Leahy, P.; Davidson, E.; Ruvkun, G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 2000, 408(6808), 86-89.
6. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75(5), 843-854.
7. Wu, P.; Zuo, X.; Ji, A. Stroke-induced microRNAs: The potential therapeutic role for stroke. Exp. Ther. Med., 2012, 3(4), 571-576.
8. Almeida, M. I.; Reis, R. M.; Calin, G. A. MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res., 2011, 717(1-2), 1-8.
9. Calin, G. A.; Dumitru, C. D.; Shimizu, M.; Bichi, R.; Zupo, S.; Noch, E.; Aldler, H.; Rattan, S.; Keating, M.; Rai, K.; Rassenti, L.; Kipps, T.; Negrini, M.; Bullrich, F.; Croce, C. M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U S A, 2002, 99(24), 15524-15529.
10. Medina, P. P.; Nolde, M.; Slack, F. J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 2010, 467(7311), 86-90.
11. Zhao, Y.; Samal, E.; Srivastava, D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436(7048), 214-220.
12. van Rooij, E.; Sutherland, L. B.; Liu, N.; Williams, A. H.; McAnally, J.; Gerard, R. D.; Richardson, J. A.; Olson, E. N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. U S A, 2006, 103(48), 18255-18260.
13. Sonkoly, E.; Wei, T.; Janson, P. C.; Saaf, A.; Lundeberg, L.; Tengvall-Linder, M.; Norstedt, G.; Alenius, H.; Homey, B.; Scheynius, A.; Stahle, M.; Pivarcsi, A. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One, 2007, 2(7), e610.
14. Dai, Y.; Huang, Y. S.; Tang, M.; Lv, T. Y.; Hu, C. X.; Tan, Y. H.; Xu, Z. M.; Yin, Y. B. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus, 2007, 16(12), 939-946.
15. Stanczyk, J.; Pedrioli, D. M.; Brentano, F.; Sanchez-Pernaute, O.; Kolling, C.; Gay, R. E.; Detmar, M.; Gay, S.; Kyburz, D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum., 2008, 58(4), 1001-1009.
16. Hugon, J.; Paquet, C. Targeting miRNAs in Alzheimer's disease. Expert Rev. Neurother, 2008, 8(11), 1615-1616.
17. Kim, J.; Inoue, K.; Ishii, J.; Vanti, W. B.; Voronov, S. V.; Murchison, E.; Hannon, G.; Abeliovich, A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science, 2007, 317(5842), 1220-1224.
18. Johnson, R.; Zuccato, C.; Belyaev, N. D.; Guest, D. J.; Cattaneo, E.; Buckley, N. J. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis., 2008, 29(3), 438-445.
19. Warlow, C.; Sudlow, C.; Dennis, M.; Wardlaw, J.; Sandercock, P. Stroke. Lancet, 2003, 362(9391), 1211-1224.
20. Donnan, G. A.; Fisher, M.; Macleod, M.; Davis, S. M. Stroke. Lancet, 2008, 371(9624), 1612-1623.
21. Feigin, V. L.; Lawes, C. M.; Bennett, D. A.; Barker-Collo, S. L.; Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol., 2009, 8(4), 355-369.
22. Adams, H. P. Jr.; Bendixen, B. H.; Kappelle, L. J.; Biller, J.; Love, B. B.; Gordon, D. L.; Marsh, E. E. 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993, 24(1), 35-41.
23. Jackson, C.; Sudlow, C. Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke, 2005, 36(4), 891-901.
24. Goldstein, L. B.; Bushnell, C. D.; Adams, R. J.; Appel, L. J.; Braun, L. T.; Chaturvedi, S.; Creager, M. A.; Culebras, A.; Eckel, R. H.; Hart, R. G.; Hinchey, J. A.; Howard, V. J.; Jauch, E. C.; Levine, S. R.; Meschia, J. F.; Moore, W. S.; Nixon, J. V.; Pearson, T. A. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2011, 42(2), 517-584.
25. Rink, C.; Khanna, S. MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics, 2011, 43(10), 521-528.
26. Heggermont, W. A.; Heymans, S. MicroRNAs are involved in endorgan damage during hypertension. Hypertension, 2012, 60(5), 1088-1093.
27. Quintavalle, M.; Condorelli, G.; Elia, L. Arterial remodeling and atherosclerosis: miRNAs involvement. Vascul. Pharmacol., 2011, 55(4), 106-110.
28. Wang, Z.; Lu, Y.; Yang, B. MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc. Res., 2011, 89(4), 710-721.
29. Dehwah, M. A.; Xu, A.; Huang, Q. MicroRNAs and type 2 diabetes/obesity. J Genet Genomics, 2012, 39(1), 11-18.
30. Sacco, J.; Adeli, K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr. Opin. Lipidol., 2012, 23(3), 220-225.
31. Saugstad, J. A. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration. J. Cereb. Blood Flow Metab., 2010, 30(9), 1564-1576.
32. Tan, J. R.; Koo, Y. X.; Kaur, P.; Liu, F.; Armugam, A.; Wong, P. T.; Jeyaseelan, K. microRNAs in stroke pathogenesis. Curr. Mol. Med., 11(2), 76-92.
33. Nelson, P.; Kiriakidou, M.; Sharma, A.; Maniataki, E.; Mourelatos, Z. The microRNA world: small is mighty. Trends Biochem. Sci., 2003, 28(10), 534-540.
34. Filipowicz, W.; Bhattacharyya, S. N.; Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet., 2008, 9(2), 102-114.
35. Vasudevan, S.; Tong, Y.; Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science, 2007, 318(5858), 1931-1934.
36. Friedman, R. C.; Farh, K. K.; Burge, C. B.; Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19(1), 92-105.
37. Fasanaro, P.; Greco, S.; Ivan, M.; Capogrossi, M. C.; Martelli, F. microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol. Ther., 2010, 125(1), 92-104.
38. Reid, G.; Kirschner, M. B.; van Zandwijk, N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit. Rev. Oncol. Hematol., 2011, 80(2), 193-208.
39. Scholer, N.; Langer, C.; Dohner, H.; Buske, C.; Kuchenbauer, F. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature. Exp. Hematol., 2010, 38(12), 1126-1130.
40. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J. J.; Lotvall, J. O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 2007, 9(6), 654-659.
41. Wang, K.; Long, B.; Zhou, J.; Li, P. F. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J. Biol. Chem., 2010, 285(16), 11903-11912.
42. Lawrie, C. H.; Gal, S.; Dunlop, H. M.; Pushkaran, B.; Liggins, A. P.; Pulford, K.; Banham, A. H.; Pezzella, F.; Boultwood, J.; Wainscoat, J. S.; Hatton, C. S.; Harris, A. L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol., 2008, 141(5), 672-675.
43. Wang, G. K.; Zhu, J. Q.; Zhang, J. T.; Li, Q.; Li, Y.; He, J.; Qin, Y. W.; Jing, Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J., 2010, 31(6), 659-666.
44. Chim, S. S.; Shing, T. K.; Hung, E. C.; Leung, T. Y.; Lau, T. K.; Chiu, R. W.; Lo, Y. M. Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem., 2008, 54(3), 482-490.
45. Li, S.; Zhu, J.; Zhang, W.; Chen, Y.; Zhang, K.; Popescu, L. M.; Ma, X.; Lau, W. B.; Rong, R.; Yu, X.; Wang, B.; Li, Y.; Xiao, C.; Zhang, M.; Wang, S.; Yu, L.; Chen, A. F.; Yang, X.; Cai, J. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation, 2011, 124(2), 175-184.
46. Ceolotto, G.; Papparella, I.; Bortoluzzi, A.; Strapazzon, G.; Ragazzo, F.; Bratti, P.; Fabricio, A. S.; Squarcina, E.; Gion, M.; Palatini, P.; Semplicini, A. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am. J. Hypertens., 2011, 24(2), 241-246.
47. Wei, Z.; Biswas, N.; Wang, L.; Courel, M.; Zhang, K.; Soler-Jover, A.; Taupenot, L.; O'Connor, D. T. A common genetic variant in the 3'-UTR of vacuolar H+-ATPase ATP6V0A1 creates a micro-RNA motif to alter chromogranin A processing and hypertension risk. Circ. Cardiovasc. Genet., 2011, 4(4), 381-389.
48. Marques, F. Z.; Campain, A. E.; Tomaszewski, M.; Zukowska-Szczechowska, E.; Yang, Y. H.; Charchar, F. J.; Morris, B. J. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension, 2011, 58(6), 1093-1098.
49. Harris, T. A.; Yamakuchi, M.; Ferlito, M.; Mendell, J. T.; Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U S A, 2008, 105(5), 1516-1521.
50. Cheng, C.; Tempel, D.; van Haperen, R.; van der Baan, A.; Grosveld, F.; Daemen, M. J.; Krams, R.; de Crom, R. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation, 2006, 113(23), 2744-2753.
51. Weber, M.; Baker, M. B.; Moore, J. P.; Searles, C. D. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem. Biophys. Res. Commun., 2010, 393(4), 643-648.
52. Chen, W. J.; Yin, K.; Zhao, G. J.; Fu, Y. C.; Tang, C. K. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis, 2012, 222(2), 314-323.
53. Girmatsion, Z.; Biliczki, P.; Bonauer, A.; Wimmer-Greinecker, G.; Scherer, M.; Moritz, A.; Bukowska, A.; Goette, A.; Nattel, S.; Hohnloser, S. H.; Ehrlich, J. R. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm, 2009, 6(12), 1802-1809.
54. Lu, Y.; Zhang, Y.; Wang, N.; Pan, Z.; Gao, X.; Zhang, F.; Shan, H.; Luo, X.; Bai, Y.; Sun, L.; Song, W.; Xu, C.; Wang, Z.; Yang, B. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation, 2010, 122(23), 2378-2387.
55. Esguerra, J. L.; Bolmeson, C.; Cilio, C. M.; Eliasson, L. Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One, 2011, 6(4), e18613.
56. Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res., 2010, 107(6), 810-817.
57. Kong, L.; Zhu, J.; Han, W.; Jiang, X.; Xu, M.; Zhao, Y.; Dong, Q.; Pang, Z.; Guan, Q.; Gao, L.; Zhao, J.; Zhao, L. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta. Diabetol., 2011, 48(1), 61-69.
58. Poy, M. N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Ma, X.; Macdonald, P. E.; Pfeffer, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; Stoffel, M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 2004, 432(7014), 226-230.
59. Poy, M. N.; Spranger, M.; Stoffel, M. microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes. Metab., 2007, 9, 67-73.
60. Lovis, P.; Roggli, E.; Laybutt, D. R.; Gattesco, S.; Yang, J. Y.; Widmann, C.; Abderrahmani, A.; Regazzi, R. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes, 2008, 57(10), 2728-2736.
61. Rayner, K. J.; Suarez, Y.; Davalos, A.; Parathath, S.; Fitzgerald, M. L.; Tamehiro, N.; Fisher, E. A.; Moore, K. J.; Fernandez-Hernando, C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science, 2010, 328(5985), 1570-1573.
62. Rayner, K. J.; Esau, C. C.; Hussain, F. N.; McDaniel, A. L.; Marshall, S. M.; van Gils, J. M.; Ray, T. D.; Sheedy, F. J.; Goedeke, L.; Liu, X.; Khatsenko, O. G.; Kaimal, V.; Lees, C. J.; Fernandez-Hernando, C.; Fisher, E. A.; Temel, R. E.; Moore, K. J. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature, 2011, 478(7369), 404-407.
63. Esau, C.; Davis, S.; Murray, S. F.; Yu, X. X.; Pandey, S. K.; Pear, M.; Watts, L.; Booten, S. L.; Graham, M.; McKay, R.; Subramaniam, A.; Propp, S.; Lollo, B. A.; Freier, S.; Bennett, C. F.; Bhanot, S.; Monia, B. P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab., 2006, 3(2), 87-98.
64. Elmen, J.; Lindow, M.; Schutz, S.; Lawrence, M.; Petri, A.; Obad, S.; Lindholm, M.; Hedtjarn, M.; Hansen, H. F.; Berger, U.; Gullans, S.; Kearney, P.; Sarnow, P.; Straarup, E. M.; Kauppinen, S. LNA-mediated microRNA silencing in non-human primates. Nature, 2008, 452(7189), 896-899.
65. Iliopoulos, D.; Drosatos, K.; Hiyama, Y.; Goldberg, I. J.; Zannis, V. I. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res., 2010, 51(6), 1513-1523.
66. Jeyaseelan, K.; Lim, K. Y.; Armugam, A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke, 2008, 39(3), 959-966.
67. Dharap, A.; Bowen, K.; Place, R.; Li, L. C.; Vemuganti, R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J. Cereb. Blood Flow Metab., 2009, 29(4), 675-687.
68. Laterza, O. F.; Lim, L.; Garrett-Engele, P. W.; Vlasakova, K.; Muniappa, N.; Tanaka, W. K.; Johnson, J. M.; Sina, J. F.; Fare, T. L.; Sistare, F. D.; Glaab, W. E. Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem., 2009, 55(11), 1977-1983.
69. Liu, D. Z.; Tian, Y.; Ander, B. P.; Xu, H.; Stamova, B. S.; Zhan, X.; Turner, R. J.; Jickling, G.; Sharp, F. R. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab., 2010, 30(1), 92-101.
70. Lee, S. T.; Chu, K.; Jung, K. H.; Yoon, H. J.; Jeon, D.; Kang, K. M.; Park, K. H.; Bae, E. K.; Kim, M.; Lee, S. K.; Roh, J. K. MicroRNAs induced during ischemic preconditioning. Stroke, 2010, 41(8), 1646-1651.
71. Lusardi, T. A.; Farr, C. D.; Faulkner, C. L.; Pignataro, G.; Yang, T.; Lan, J.; Simon, R. P.; Saugstad, J. A. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab., 2010, 30(4), 744-756.
72. Dharap, A.; Vemuganti, R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J. Neurochem., 2010, 113(6), 1685-1691.
73. Yin, K. J.; Deng, Z.; Huang, H.; Hamblin, M.; Xie, C.; Zhang, J.; Chen, Y. E. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis., 2010, 38(1), 17-26.
74. Yin, K. J.; Deng, Z.; Hamblin, M.; Xiang, Y.; Huang, H.; Zhang, J.; Jiang, X.; Wang, Y.; Chen, Y. E. Peroxisome proliferatoractivated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J. Neurosci., 2010, 30(18), 6398-6408.
75. Buller, B.; Liu, X.; Wang, X.; Zhang, R. L.; Zhang, L.; Hozeska-Solgot, A.; Chopp, M.; Zhang, Z. G. MicroRNA-21 protects neurons from ischemic death. FEBS J., 2010, 277(20), 4299-4307.
76. Yuan, Y.; Wang, J. Y.; Xu, L. Y.; Cai, R.; Chen, Z.; Luo, B. Y. MicroRNA expression changes in the hippocampi of rats subjected to global ischemia. J. Clin. Neurosci., 2010, 17(6), 774-778.
77. Weng, H.; Shen, C.; Hirokawa, G.; Ji, X.; Takahashi, R.; Shimada, K.; Kishimoto, C.; Iwai, N. Plasma miR-124 as a biomarker for cerebral infarction. Biomed. Res., 2011, 32(2), 135-141.
78. Liu, X. S.; Chopp, M.; Zhang, R. L.; Tao, T.; Wang, X. L.; Kassis, H.; Hozeska-Solgot, A.; Zhang, L.; Chen, C.; Zhang, Z. G. MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS One, 2011, 6(8), e23461.
79. Ouyang, Y. B.; Lu, Y.; Yue, S.; Xu, L. J.; Xiong, X. X.; White, R. E.; Sun, X.; Giffard, R. G. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol. Dis., 2012, 45(1), 555-563.
80. Shi, G.; Liu, Y.; Liu, T.; Yan, W.; Liu, X.; Wang, Y.; Shi, J.; Jia, L. Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp. Brain Res., 2012, 216(2), 225-230.
81. Selvamani, A.; Sathyan, P.; Miranda, R. C.; Sohrabji, F. An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One, 2012, 7(2), e32662.
82. Hunsberger, J. G.; Fessler, E. B.; Wang, Z.; Elkahloun, A. G.; Chuang, D. M. Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia. Am. J. Transl. Res., 2012, 4(3), 316-332.
83. Lou, Y. L.; Guo, F.; Liu, F.; Gao, F. L.; Zhang, P. Q.; Niu, X.; Guo, S. C.; Yin, J. H.; Wang, Y.; Deng, Z. F. miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol. Cell Biochem., 2012, 370(1-2), 45-51.
84. Yin, K. J.; Fan, Y.; Hamblin, M.; Zhang, J.; Zhu, T.; Li, S.; Hawse, J. R.; Subramaniam, M.; Song, C. Z.; Urrutia, R.; Lin, J. D.; Chen, Y. E. KLF11 mediates PPARgamma cerebrovascular protection in ischaemic stroke. Brain, 2013, 136(Pt 4), 1274-1287.
85. Guo, Q.; Sayeed, I.; Baronne, L. M.; Hoffman, S. W.; Guennoun, R.; Stein, D. G. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol., 2006, 198(2), 469-478.
86. Raghavendra Rao, V. L.; Bowen, K. K.; Dhodda, V. K.; Song, G.; Franklin, J. L.; Gavva, N. R.; Dempsey, R. J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem., 2002, 83(5), 1072-1086.
87. Boissonneault, V.; Plante, I.; Rivest, S.; Provost, P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J. Biol. Chem., 2009, 284(4), 1971-1981.
88. Tsitsiou, E.; Lindsay, M. A. microRNAs and the immune response. Curr. Opin. Pharmacol., 2009, 9(4), 514-520.
89. Dirnagl, U.; Simon, R. P.; Hallenbeck, J. M. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci., 2003, 26(5), 248-254.
90. Bruick, R. K.; McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 2001, 294(5545), 1337-1340.
91. Klein, M. E.; Lioy, D. T.; Ma, L.; Impey, S.; Mandel, G.; Goodman, R. H. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci., 2007, 10(12), 1513-1514.
92. Arsham, A. M.; Howell, J. J.; Simon, M. C. A novel hypoxiainducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem., 2003, 278(32), 29655-29660.
93. Johnson, G. L.; Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 2002, 298(5600), 1911-1912.
94. Cheung, L. W.; Wong, A. S. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J., 2008, 275(22), 5479-5495.
95. Cheng, L. C.; Pastrana, E.; Tavazoie, M.; Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci., 2009, 12(4), 399-408.
96. Wang, L.; Chopp, M.; Zhang, R. L.; Zhang, L.; Letourneau, Y.; Feng, Y. F.; Jiang, A.; Morris, D. C.; Zhang, Z. G. The Notch pathway mediates expansion of a progenitor pool and neuronal differentiation in adult neural progenitor cells after stroke. Neuroscience, 2009, 158(4), 1356-1363.
97. Kim, H. J.; Rowe, M.; Ren, M.; Hong, J. S.; Chen, P. S.; Chuang, D. M. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther., 2007, 321(3), 892-901.
98. Dong, S.; Cheng, Y.; Yang, J.; Li, J.; Liu, X.; Wang, X.; Wang, D.; Krall, T. J.; Delphin, E. S.; Zhang, C. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem., 2009, 284(43), 29514-29525.
99. Sairanen, T.; Karjalainen-Lindsberg, M. L.; Paetau, A.; Ijas, P.; Lindsberg, P. J. Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments. Brain, 2006, 129(Pt 1), 189-199.
100. Hoehn, B.; Ringer, T. M.; Xu, L.; Giffard, R. G.; Sapolsky, R. M.; Steinberg, G. K.; Yenari, M. A. Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J. Cereb. Blood Flow Metab., 2001, 21(11), 1303-1309.
101. Ziu, M.; Fletcher, L.; Rana, S.; Jimenez, D. F.; Digicaylioglu, M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS One, 2011, 6(2), e14724.
102. Gluckman, P.; Klempt, N.; Guan, J.; Mallard, C.; Sirimanne, E.; Dragunow, M.; Klempt, M.; Singh, K.; Williams, C.; Nikolics, K. A role for IGF-1 in the rescue of CNS neurons following hypoxicischemic injury. Biochem. Biophys. Res. Commun., 1992, 182(2), 593-599.
103. Liu, X. F.; Fawcett, J. R.; Hanson, L. R.; Frey, W. H. 2nd The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. J. Stroke Cerebrovasc. Dis., 2004, 13(1), 16-23.
104. Chan, S. Y.; Loscalzo, J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle, 2010, 9(6), 1072-1083.
105. Tan, K. S.; Armugam, A.; Sepramaniam, S.; Lim, K. Y.; Setyowati, K. D.; Wang, C. W.; Jeyaseelan, K. Expression profile of MicroRNAs in young stroke patients. PLoS One, 2009, 4(11), e7689.
106. Chen, J.; Yang, T.; Yu, H.; Sun, K.; Shi, Y.; Song, W.; Bai, Y.; Wang, X.; Lou, K.; Song, Y.; Zhang, Y.; Hui, R. A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211. Hum. Mol. Genet., 2010, 19(12), 2524-2533.
107. Zeng, L.; Liu, J.; Wang, Y.; Wang, L.; Weng, S.; Tang, Y.; Zheng, C.; Cheng, Q.; Chen, S.; Yang, G. Y. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci. (Elite Ed), 2011, 3, 1265-1272.
108. Gan, C. S.; Wang, C. W.; Tan, K. S. Circulatory microRNA-145 expression is increased in cerebral ischemia. Genet. Mol. Res., 2012, 11(1), 147-152.
109. Tan, J. R.; Tan, K. S.; Koo, Y. X.; Yong, F. L.; Wang, C. W.; Armugam, A.; Jeyaseelan, K. Blood microRNAs in Low or No Risk Ischemic Stroke Patients. Int. J. Mol. Sci., 2013, 14(1), 2072-2084.
110. Zheng, H. W.; Wang, Y. L.; Lin, J. X.; Li, N.; Zhao, X. Q.; Liu, G. F.; Liu, L. P.; Jiao, Y.; Gu, W. K.; Wang, D. Z.; Wang, Y. J. Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage. CNS Neurosci. Ther., 2012, 18(12), 1003-1011.
111. Thurston, G.; Suri, C.; Smith, K.; McClain, J.; Sato, T. N.; Yancopoulos, G. D.; McDonald, D. M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science, 1999, 286(5449), 2511-2514.
112. Cordes, K. R.; Sheehy, N. T.; White, M. P.; Berry, E. C.; Morton, S. U.; Muth, A. N.; Lee, T. H.; Miano, J. M.; Ivey, K. N.; Srivastava, D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 2009, 460(7256), 705-710.
113. van Rooij, E.; Purcell, A. L.; Levin, A. A. Developing microRNA therapeutics. Circ. Res., 2012, 110(3), 496-507.
114. Krutzfeldt, J.; Rajewsky, N.; Braich, R.; Rajeev, K. G.; Tuschl, T.; Manoharan, M.; Stoffel, M. Silencing of microRNAs in vivo with 'antagomirs'. Nature, 2005, 438(7068), 685-689.
115. Kota, J.; Chivukula, R. R.; O'Donnell, K. A.; Wentzel, E. A.; Montgomery, C. L.; Hwang, H. W.; Chang, T. C.; Vivekanandan, P.; Torbenson, M.; Clark, K. R.; Mendell, J. R.; Mendell, J. T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell, 2009, 137(6), 1005-1017.